HCSG on Nasdaq
HEALTHCARE SERVICES GROUP INC
American nursing and personal care facilities services company. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Brookdale Senior Living, Sonida Senior Living or Superconductor Technologies, or pick any stock.
- TickerHCSG on Nasdaq2
- IndustryServices-Nursing & Personal Care Facilities2
- HeadquartersBensalem, United States2
- Incorporated inPA3
- Business address3220 Tillman Drive, Suite 300, Bensalem, Pa 190203
- Filer categoryLarge accelerated filer3
- Legal formCorporation2
- LEI529900GVZ1D2FBYMS7192
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered address3220 Tillman Drive, Suite 300, 19020 Bensalem, United States2
- Registered withPennsylvania Department of State, 6419442
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Dietary Services brought in 55% of the revenue HEALTHCARE SERVICES GROUP INC broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Dietary Services | $904.7M | $950.3M | $1.0B |
| Environmental Services | $766.7M | $765.4M | $824.7M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue86¢$1.6B
- Selling, general and admin10¢$190.9M
- Income tax0¢$8.8M
- Profit3¢$59.1M
Out of $1.8B in revenue.4
Where each dollar of operating cash went, fiscal 2025
- Capital spending4¢$5.8M
- Share buybacks42¢$61.6M
- Kept or used elsewhere54¢$77.6M
Out of $145.0M of cash from operations.4
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenues | $1.8B | $1.7B | $1.7B |
| Costs of services provided | $1.6B | $1.5B | $1.5B |
| Selling, general and administrative expenses | $190.9M | $183.1M | $166.8M |
| Investment and other income, net | $20.9M | $14.3M | $12.9M |
| Interest expense | -$1.6M | -$6.4M | -$7.9M |
| Income before taxes | $67.9M | $52.9M | $53.1M |
| Income tax provision | $8.8M | $13.5M | $14.7M |
| Net income | $59.1M | $39.5M | $38.4M |
| Basic earnings per common share (in dollars per share) | $0.82 | $0.54 | $0.52 |
| Diluted earnings per common share (in dollars per share) | $0.81 | $0.53 | $0.52 |
| Basic (in shares) | 72.4M shares | 73.8M shares | 74.3M shares |
| Diluted (in shares) | 73.0M shares | 74.0M shares | 74.3M shares |
| Unrealized gain on available-for-sale marketable securities, net of taxes | $1.9M | -$473.0K | $1.6M |
| Total comprehensive income | $60.9M | $39.0M | $40.0M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $125.2M | $56.8M | $54.3M | |
| Restricted cash equivalents | $5.6M | $3.4M | ||
| Marketable securities, at fair value | $42.8M | $50.5M | ||
| Restricted marketable securities, at fair value | $30.4M | $25.1M | ||
| Accounts receivable (less allowances: $119,305 and $87,520) | $281.3M | $330.9M | ||
| Notes receivable shortterm portion (less allowances: $25,931 and $10,372) | $31.2M | $51.4M | ||
| Inventories and supplies | $16.8M | $16.7M | ||
| Income taxes receivable | $22.2M | $0 | ||
| Prepaid expenses and other current assets | $20.9M | $21.8M | ||
| Total current assets | $576.4M | $556.7M | ||
| Property and equipment, net | $27.6M | $28.2M | ||
| Goodwill | $79.8M | $75.5M | ||
| Other intangible assets (less accumulated amortization of $42,931 and $39,242) | $7.0M | $9.4M | ||
| Notes receivable longterm portion (less allowances: $1,776 and $2,890) | $25.2M | $41.1M | ||
| Deferred compensation funding, at fair value | $55.9M | $49.6M | ||
| Deferred tax assets | $18.5M | $38.2M | ||
| Other long-term assets | $3.9M | $4.1M | ||
| Total assets | $794.3M | $802.8M | ||
| Accounts payable | $77.4M | $81.1M | ||
| Accrued payroll and related taxes | $31.4M | $51.6M | ||
| Other accrued expenses and current liabilities | $37.2M | $26.3M | ||
| Income taxes payable | $0 | $8.4M | ||
| Accrued insurance claims | $24.4M | $25.1M | ||
| Total current liabilities | $170.4M | $192.5M | ||
| Accrued insurance claims long-term | $46.1M | $51.9M | ||
| Deferred compensation liability long-term | $56.3M | $50.0M | ||
| Lease liability long-term | $9.7M | $8.0M | ||
| Other long-term liabilities | $1.6M | $385.0K | ||
| Common stock, $0.01 par value; 200,000 shares authorized; 76,821 and 76,533 shares issued, and 69,596 and 73,203 shares outstanding | $768.0K | $765.0K | ||
| Additional paid-in capital | $328.0M | $318.4M | ||
| Retained earnings | $283.7M | $224.6M | ||
| Accumulated other comprehensive loss, net of taxes | -$448.0K | -$2.3M | ||
| Common stock in treasury, at cost; 7,225 and 3,330 shares | -$101.7M | -$41.4M | ||
| Total stockholders equity | $510.2M | $499.9M | $456.6M | $418.3M |
| Total liabilities and stockholders equity | $794.3M | $802.8M | ||
| Allowance for doubtful accounts, current | $119.3M | $87.5M | ||
| Financing receivable, allowance for credit loss, current | $25.9M | $10.4M | ||
| Accumulated amortization of other intangible assets | $42.9M | $39.2M | ||
| Allowance for doubtful accounts, noncurrent | $1.8M | $2.9M | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common stock, authorized (in shares) | 200.0M shares | 200.0M shares | ||
| Common stock, issued (in shares) | 76.8M shares | 76.5M shares | ||
| Common stock, outstanding (in shares) | 69.6M shares | 73.2M shares | ||
| Common stock in treasury (in shares) | 7.2M shares | 3.3M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $125.2M | $56.8M | $54.3M | |
| Restricted cash equivalents | $5.6M | $3.4M | ||
| Marketable securities, at fair value | $42.8M | $50.5M | ||
| Restricted marketable securities, at fair value | $30.4M | $25.1M | ||
| Accounts receivable (less allowances: $119,305 and $87,520) | $281.3M | $330.9M | ||
| Notes receivable shortterm portion (less allowances: $25,931 and $10,372) | $31.2M | $51.4M | ||
| Inventories and supplies | $16.8M | $16.7M | ||
| Income taxes receivable | $22.2M | $0 | ||
| Prepaid expenses and other current assets | $20.9M | $21.8M | ||
| Total current assets | $576.4M | $556.7M | ||
| Property and equipment, net | $27.6M | $28.2M | ||
| Goodwill | $79.8M | $75.5M | ||
| Other intangible assets (less accumulated amortization of $42,931 and $39,242) | $7.0M | $9.4M | ||
| Notes receivable longterm portion (less allowances: $1,776 and $2,890) | $25.2M | $41.1M | ||
| Deferred compensation funding, at fair value | $55.9M | $49.6M | ||
| Deferred tax assets | $18.5M | $38.2M | ||
| Other long-term assets | $3.9M | $4.1M | ||
| Total assets | $794.3M | $802.8M | ||
| Accounts payable | $77.4M | $81.1M | ||
| Accrued payroll and related taxes | $31.4M | $51.6M | ||
| Other accrued expenses and current liabilities | $37.2M | $26.3M | ||
| Income taxes payable | $0 | $8.4M | ||
| Accrued insurance claims | $24.4M | $25.1M | ||
| Total current liabilities | $170.4M | $192.5M | ||
| Accrued insurance claims long-term | $46.1M | $51.9M | ||
| Deferred compensation liability long-term | $56.3M | $50.0M | ||
| Lease liability long-term | $9.7M | $8.0M | ||
| Other long-term liabilities | $1.6M | $385.0K | ||
| Common stock, $0.01 par value; 200,000 shares authorized; 76,821 and 76,533 shares issued, and 69,596 and 73,203 shares outstanding | $768.0K | $765.0K | ||
| Additional paid-in capital | $328.0M | $318.4M | ||
| Retained earnings | $283.7M | $224.6M | ||
| Accumulated other comprehensive loss, net of taxes | -$448.0K | -$2.3M | ||
| Common stock in treasury, at cost; 7,225 and 3,330 shares | -$101.7M | -$41.4M | ||
| Total stockholders equity | $510.2M | $499.9M | $456.6M | $418.3M |
| Total liabilities and stockholders equity | $794.3M | $802.8M | ||
| Allowance for doubtful accounts, current | $119.3M | $87.5M | ||
| Financing receivable, allowance for credit loss, current | $25.9M | $10.4M | ||
| Accumulated amortization of other intangible assets | $42.9M | $39.2M | ||
| Allowance for doubtful accounts, noncurrent | $1.8M | $2.9M | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common stock, authorized (in shares) | 200.0M shares | 200.0M shares | ||
| Common stock, issued (in shares) | 76.8M shares | 76.5M shares | ||
| Common stock, outstanding (in shares) | 69.6M shares | 73.2M shares | ||
| Common stock in treasury (in shares) | 7.2M shares | 3.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $59.1M | $39.5M | $38.4M |
| Depreciation and amortization | $16.8M | $14.6M | $14.3M |
| Bad debt provision | $83.1M | $46.8M | $35.6M |
| Deferred income taxes | $19.2M | -$2.9M | -$4.8M |
| Share-based compensation expense | $12.0M | $9.2M | $9.0M |
| Amortization of premium on marketable securities | $295.0K | $1.5M | $2.1M |
| Unrealized gain on deferred compensation fund investments | -$7.3M | -$8.2M | -$6.6M |
| Changes in other long-term liabilities | -$384.0K | -$564.0K | -$1.2M |
| Net loss on disposals of property and equipment | $422.0K | $654.0K | $818.0K |
| Share of loss from equity method investment | $2.4M | $532.0K | $0 |
| Accounts and notes receivable | $5.2M | -$61.8M | -$74.6M |
| Inventories and supplies | -$48.0K | $1.7M | $2.7M |
| Prepaid expenses and other assets | $2.6M | $704.0K | $12.8M |
| Deferred compensation funding | $318.0K | -$534.0K | -$674.0K |
| Accounts payable and other accrued expenses and current liabilities | -$12.1M | -$9.7M | $7.4M |
| Deferred ERC Credits | $12.3M | $0 | $0 |
| Accrued payroll and related taxes | -$19.2M | -$3.6M | $4.2M |
| Income taxes receivable (payable) | -$30.6M | $1.2M | $572.0K |
| Accrued insurance claims | -$6.5M | -$7.4M | -$4.3M |
| Deferred compensation liability | $7.4M | $9.2M | $7.8M |
| Net cash from operating activities | $145.0M | $30.8M | $43.5M |
| Proceeds from disposals of property and equipment | $105.0K | $211.0K | $121.0K |
| Additions to property and equipment | -$5.8M | -$6.3M | -$5.4M |
| Cash paid for acquisition | -$7.2M | $0 | $0 |
| Cash paid for investments | -$2.6M | -$2.8M | $0 |
| Purchases of marketable securities | -$18.7M | -$52.1M | $0 |
| Sales of marketable securities | $23.2M | $67.0M | $2.0M |
| Net cash from investing activities | -$11.0M | $6.0M | -$3.3M |
| Purchases of treasury stock | -$61.6M | -$5.0M | -$11.3M |
| Repayments of short-term borrowings | $0 | -$25.0M | $0 |
| Payments of statutory withholding on net issuance of common stock | -$1.7M | -$1.0M | -$871.0K |
| Net cash from financing activities | -$63.3M | -$31.0M | -$12.2M |
| Net increase in cash, cash equivalents, and restricted cash equivalents | $70.6M | $5.8M | $28.1M |
| Cash paid for interest | $1.7M | $6.5M | $7.8M |
No quarter-by-quarter statement was filed.
Leadership
Who has led HEALTHCARE SERVICES GROUP INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
2010201520202025
- Chief executive officerTheodore Wahl Aug 3, 2015 to now12
- Chief executive officerDaniel P. McCartney Jan 5, 2006 to Jan 6, 201513
- ChairDaniel P. McCartney Jan 22, 2007 to Jan 22, 200714
- PresidentTheodore Wahl Jan 8, 2013 to now15
- Chief financial officerVikas Singh Sep 11, 2024 to now16
- Chief financial officerJohn Christopher Shea Jan 8, 2013 to Jan 5, 202217
- Chief financial officerRichard W. Hudson Apr 27, 2007 to Mar 12, 201218
- Chief financial officerJames L. Distefano Jan 5, 2006 to May 4, 200719
- Chief operating officerAndrew Kush Dec 4, 2020 to now20
- Chief operating officerDavid Hurlock Jul 21, 2017 to Jan 4, 201921
- Chief operating officerTheodore Wahl Sep 26, 2011 to Jan 5, 201522
Board members and other officers (25)
- EVP & Chief Revenue OfficerPatrick J. Orr Jan 4, 2021 to now23
- EVP/Gen. Counsel/Corp. Secty.Jason J. Bundick Jan 6, 2021 to now24
- Acting Accounting OfficerAndrew M. Brophy Mar 8, 2021 to now25
- Executive Vice PresidentAndrew Kush Apr 21, 2017 to Jan 6, 202026
- Executive Vice PresidentBryan D. McCartney Apr 9, 2012 to Feb 14, 201727
- Sr VP of OperationsMichael E. McBryan May 27, 2011 to Nov 16, 202028
- Chief Accounting OfficerJohn Christopher Shea Oct 7, 2010 to now29
- Vice President FinanceTheodore Wahl Jan 16, 2009 to Jan 7, 201130
- Vice PresidentJoseph F. McCartney Jan 5, 2006 to Jan 8, 201331
- Vice PresidentRichard W. Hudson Jan 5, 2006 to Jun 15, 201232
- Board memberThomas Gerard Whalen Jun 4, 2025 to now33
- Board memberKurt Simmons Jr. Nov 10, 2021 to now34
- Board memberLaura K. Grant May 29, 2020 to now35
- Board memberDaniela Castagnino Jun 8, 2018 to now36
- Board memberJude Visconto Jun 16, 2015 to now37
- Board memberDiane S. Casey May 27, 2011 to now38
- Board memberMichael E. McBryan May 27, 2011 to Feb 5, 202128
- Board memberTheodore Wahl Sep 26, 2011 to now22
- Board memberRobert J. Moss Jun 15, 2007 to Jan 6, 202039
- Board memberDino D. Ottaviano Jun 19, 2007 to now40
- Board memberDaniel P. McCartney Jan 5, 2006 to May 15, 201713
- Board memberJoseph F. McCartney Jan 5, 2006 to Jan 8, 201331
- Board memberBarton D. Weisman Feb 22, 2006 to Apr 29, 200941
- Board memberRobert L. Frome Jul 27, 2006 to now42
- General counselJason J. Bundick Dec 19, 2013 to Jan 6, 202043
Timeline
Filings
277 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 35 major events, 159 insider forms, 30 large holders, 33 other. The latest 20:
- Oct 7, 20268-K EDGAR
- Oct 1, 20264 EDGAR
- Oct 1, 20264 EDGAR
- Oct 1, 20264 EDGAR
- Aug 5, 20264 EDGAR
- Aug 4, 2026144 EDGAR
- Jul 24, 2026S-8 EDGAR
- Jul 24, 202610-Q EDGAR
- Jul 22, 20268-K EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- May 29, 20264/A EDGAR
- May 28, 20264 EDGAR
- May 28, 20264 EDGAR
- May 28, 20264 EDGAR
- May 28, 20264 EDGAR
- May 28, 20264 EDGAR
- May 28, 20264 EDGAR
The 277 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
11 open-market trades by officers, directors and large owners since October 2021: 1 buys and 10 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Kush AndrewEVP & Chief Operating Officer | Sale | 15,598 | $23.24 | $362.5K | Form 4 |
| Feb 26, 2026 | Brophy Andrew MSVP & Chief Accounting Officer | Sale | 2,490 | $21.75 | $54.2K | Form 4 |
| Feb 18, 2026 | Orr Patrick JEVP & Chief Revenue Officer | Sale | 44,615 | $20.53 | $915.8K | Form 4 |
| Feb 18, 2026 | Orr Patrick JEVP & Chief Revenue Officer | Sale | 45,500 | $20.54 | $934.6K | Form 4 |
| Feb 18, 2026 | SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer | Sale | 54,357 | $20.41 | $1.1M | Form 4 |
| Jul 28, 2025 | SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer | Sale | 21,368 | $13.25 | $283.1K | Form 4 |
| Feb 26, 2025 | Brophy Andrew MSVP & Chief Accounting Officer | Sale | 1,744 | $10.45 | $18.2K | Form 4 |
| Feb 28, 2024 | Brophy Andrew MSVP & Chief Accounting Officer | Sale | 1,125 | $12.58 | $14.2K | Form 4 |
| Jun 30, 2023 | Simmons Kurt JRDirector | Buy | 1,005 | $14.93 | $15.0K | Form 4 |
| Feb 24, 2023 | Brophy Andrew MSVP & Chief Accounting Officer | Sale | 951 | $13.41 | $12.8K | Form 4 |
| Nov 23, 2021 | BRIGGS JOHNDirector | Sale | 5,001 | $18.71 | $93.6K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- MACKENZIE FINANCIAL CORPSCHEDULE 13G/A, 10 filings Feb 4, 2022 to May 15, 202644
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 202645
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202646
- VANGUARD GROUP INCSCHEDULE 13G/A, 4 filings Feb 10, 2022 to Mar 27, 202647
- ROYCE & ASSOCIATES LPSCHEDULE 13G/A, 3 filings Jan 23, 2024 to Jul 16, 202548
- BlackRockSC 13G/A, 2 filings Oct 18, 2024 to Nov 8, 202449
- InvescoSC 13G/A, 2 filings Feb 10, 2023 to Feb 1, 202450
- State Street CorporationSC 13G/A, 2 filings Feb 1, 2023 to Jan 22, 202451
- RIVERBRIDGE PARTNERS LLCSC 13G/A, 1 filing Jan 21, 202252
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 11,375,365 | $279.4M | 0.0% | −83,231 |
| Vanguard Portfolio Management LLC | 5,080,313 | $124.8M | 0.0% | +234,180 |
| Vanguard Capital Management LLC | 3,040,374 | $74.7M | 0.0% | −79,171 |
| State Street Corp | 2,916,008 | $71.6M | 0.0% | +96,883 |
| American Century Companies Inc | 2,661,455 | $65.4M | 0.0% | +153,028 |
| Geode Capital Management, LLC | 2,562,011 | $62.9M | 0.0% | +517,415 |
| Dimensional Fund Advisors LP | 2,484,818 | $61.0M | 0.0% | +84,137 |
| Fmr LLC | 2,296,772 | $56.4M | 0.0% | +329,978 |
| Ameriprise Financial Inc | 2,255,190 | $55.4M | 0.0% | +89,446 |
| Royce & Associates LP | 2,239,224 | $55.0M | 0.4% | +95,987 |
| Arrowstreet Capital, Limited Partnership | 1,443,054 | $35.4M | 0.0% | +37,102 |
| Franklin Resources Inc | 1,244,416 | $30.6M | 0.0% | +83,194 |
| Charles Schwab Investment Management Inc | 1,165,139 | $28.6M | 0.0% | −158,133 |
| Nuveen, LLC | 1,127,400 | $27.7M | 0.0% | −45,004 |
| First Eagle Investment Management, LLC | 1,096,070 | $26.9M | 0.0% | +621,535 |
| Morgan Stanley | 1,049,627 | $25.8M | 0.0% | +38,903 |
| Pembroke Management, LTD | 1,046,450 | $25.7M | 1.8% | +747,365 |
| Invesco Ltd. | 994,507 | $24.4M | 0.0% | +168,237 |
| Aqr Capital Management LLC | 974,997 | $23.7M | 0.0% | −112,483 |
| Goldman Sachs Group Inc | 962,865 | $23.6M | 0.0% | −225,552 |
| Qube Research & Technologies Ltd | 941,010 | $23.1M | 0.0% | −56,098 |
| Jupiter Topco LLC | 912,261 | $22.4M | 0.0% | New |
| Mackenzie Financial Corp | 856,834 | $21.0M | 0.0% | −1,815,380 |
| Marathon Asset Management Ltd | 759,824 | $18.7M | 0.8% | −211,643 |
| Northern Trust Corp | 743,729 | $18.3M | 0.0% | +69,503 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
1 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Apr 30, 2020 | Greg Gianforte, House | Buy | $50,001 - $100,000 | −181.6% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARDaniel P. McCartney, Chair
- 15SEC EDGARTheodore Wahl, President
- 16SEC EDGARVikas Singh, Chief financial officer
- 17
- 18
- 19
- 20SEC EDGARAndrew Kush, Chief operating officer
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31SEC EDGARJoseph F. McCartney, Vice President
- 32SEC EDGARRichard W. Hudson, Vice President
- 33SEC EDGARThomas Gerard Whalen, Board member
- 34SEC EDGARKurt Simmons Jr., Board member
- 35SEC EDGARLaura K. Grant, Board member
- 36SEC EDGARDaniela Castagnino, Board member
- 37SEC EDGARJude Visconto, Board member
- 38SEC EDGARDiane S. Casey, Board member
- 39SEC EDGARRobert J. Moss, Board member
- 40SEC EDGARDino D. Ottaviano, Board member
- 41SEC EDGARBarton D. Weisman, Board member
- 42SEC EDGARRobert L. Frome, Board member
- 43SEC EDGARJason J. Bundick, General counsel
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52